Search

Home > OncLive® On Air > 4: FDA Approval Insights: Liso-Cel in Refractory Large B-Cell Lymphoma
Podcast: OncLive® On Air
Episode:

4: FDA Approval Insights: Liso-Cel in Refractory Large B-Cell Lymphoma

Category: Science & Medicine
Duration: 00:10:03
Publish Date: 2021-05-03 20:12:27
Description: Dr. Abramson discusses the significance of the FDA approval of liso-cel in refractory large B-cell lymphoma and provided insight into the efficacy and safety profiles of the CAR T-cell therapy as reported in the TRANSCEND NHL 001 trial.
Total Play: 0

Some more Podcasts by Audioboom

70+ Episodes
100+ Episodes
Videnskab.dk .. 5     1
20+ Episodes
10+ Episodes
Odd Jobs    
20+ Episodes
100+ Episodes
Ladies of Li .. 4     3
100+ Episodes
10+ Episodes